News and Updates

CONTROLLED SUBSTANCE PRESCRIPTIONS

Please be advised that, due to international travel, Dr. Young will be unable to sign prescriptions for controlled substance medications WEDNESDAY, MAY 23, 2012 THROUGH MONDAY, MAY 28, 2012.  All prescriptions requested during this time will be filled on TUESDAY, MAY 29, 2012. Controlled substances include:  Adderall, Adderall XR, Concerta, Daytrana, Dexedrine, Focalin, Focalin XR, Methylin, Ritalin, and Vyvanse.

Thank you for your cooperation!

 



CONSTRUCTION AROUND RCBM!

****Please be advised that many of the major roadways around our office are currently under construction.  Please keep this in mind and allow extra time when driving to your appointment.  Drive safely!****



Drawing the Lines of Mental Disorders

Dr Young’s letter to the New York Times, published on February 2, 2012

Read the Letter



New and Improved Website

We are pleased to have launched our new and improved website!  We have updated our prescriptions and form submission pages and have added a wealth of useful information about RCBM.  Please take some time to peruse the new site, and do let us know what you think!



Submit Prescription Requests

Our website allows RCBM patients to submit prescription requests directly to our staff, to be processed within 24-48 hours of receipt. We encourage you to take advantage of this effective way of getting your prescriptions expedited. Prescriptions submitted electronically can be processed more quickly than messages left on our voicemail system.



Enchanced Electronic Prescribing System

Please note that we have a new electronic prescribing system. With this new system, most of our medication prescriptions can be sent electronically directly to the pharmacy for you to pick up. It is a quick and safe way to prescribe with this new software.



Video/Audio/Press


Browse the Video Library

Clinical Research Trials

RCBM is currently involved in clinical trials on the following research topics:

  • Major Depressive Disorder (trial for adults ages 18-65)
  • Anxiety (pediatric patients ages 6-17)
  • AD/HD -Attention Deficit/Hyperactivity Disorder:  (Children and adolescents ages 6-17)
  • Smoking cessation study for adolescents: (ages 12-19)

 
Please contact our research coordinators for more information!
Call (248) 608-8800
Karolina at ext. 249 or Emma at ext. 226